{"transactions":[{"id":770344,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":45748,"kind":"person","name":"Dagher Ibrahim B.","position":1,"cik":"0002019599","reported_name":"Dagher Ibrahim B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-20T22:00:34.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0.7,"value":157500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Options shall vest as to (i) 50% of the award on the date of grant and (ii) the remaining 50% of the award shall vest on the six-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date."}],"balance_after":225000,"derivative":{"exercise_price":0.7,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001104659-26-064650","document":"tm267728-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465926064650/tm267728-1_4seq1.xml","form_type":"4"}},{"id":1308493,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":45748,"kind":"person","name":"Dagher Ibrahim B.","position":1,"cik":"0002019599","reported_name":"Dagher Ibrahim B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-07T21:11:08.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date."}],"balance_after":66849,"source":{"system":"sec-edgar","filing":"0001104659-25-001674","document":"tm251864-11_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465925001674/tm251864-11_4seq1.xml","form_type":"4"}},{"id":1449542,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":45748,"kind":"person","name":"Dagher Ibrahim B.","position":1,"cik":"0002019599","reported_name":"Dagher Ibrahim B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-07-24T20:05:18.000Z","date":"2024-07-19","kind":"sale","planned":false,"acquired":false,"shares":63000,"price":0.3503,"value":22068.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.3455 to $0.366, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-082328","document":"tm2420104-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924082328/tm2420104-1_4seq1.xml","form_type":"4"}}]}